slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 33,781-33,810
Pages 1,371
Rows per page 30
Component
33,781-33,810 of 41,127
02
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Setup1 hit
13
The chart shows a bridge from starting cash flow to net change in cash.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · EvidenceLoop · Pareto Focus1 hit
18
Includes a detailed footnote explaining the definition and limitations of EBITDA as a non-GAAP measure.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations 1 hit
02
Nuvalent | Investor Presentation Deck | 42 slidesNuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
14
The slide uses a matrix-style comparison to highlight the superior coverage of NVL-655 compared to 1st, 2nd, and 3rd generation inhibitors.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
15
The slide uses a split-screen layout to contrast in vitro IC50 data with in vivo tumor regression data.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
18
Clinical trial baseline characteristics table.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
19
Data cut-off: 8 Aug 2023. Includes detailed breakdown of response by mutation type and prior treatment history.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
20
Clinical trial data (ALKOVE-1) showing efficacy of NVL-655 in NSCLC patients.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
22
Includes two patient case studies with MRI scans showing tumor reduction.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
23
Data cut-off: 8 Aug 2023. N=93 patients.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
26
Includes a table detailing patient cohorts and study objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
The slide uses three distinct chart types to demonstrate competitive superiority in potency, CNS penetration, and selectivity.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
32
Clinical trial baseline characteristics table.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
36
The slide highlights the Recommended Phase 2 Dose (RP2D) selection based on safety and PK data.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
40
The slide uses dot plots to show IC50 and selectivity index across various cell lines, and a bar chart for brain exposure in rats.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
03
Oatly | Results Presentation Deck | 43 slidesOatly | Results Presentation Deck | 43 slides · Oatly
Conference presentation Investor relations 1 hit
30
The slide uses a simple list-based layout to communicate key financial targets.Oatly | Results Presentation Deck | 43 slides · Oatly
Conference presentation Investor relations Beat · Satisfaction1 hit
33
The slide uses pie charts to visualize the revenue mix per region for Q1 2024.Oatly | Results Presentation Deck | 43 slides · Oatly
Conference presentation Investor relations 1 hit
37
The table details adjustments including share-based compensation, restructuring costs, and asset impairment charges related to discontinued production facilities.Oatly | Results Presentation Deck | 43 slides · Oatly
Conference presentation Investor relations 1 hit
39
Standard financial disclosure slide for non-IFRS metrics.Oatly | Results Presentation Deck | 43 slides · Oatly
Conference presentation Investor relations 1 hit
04
Includes a non-GAAP disclaimer at the bottom.South Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations 1 hit
05
Includes non-GAAP disclosure note at the bottom.South Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
06
Includes non-GAAP financial measure disclosure.South Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
12
The table provides a granular view of loan portfolios across various property types, including geographic distribution metrics.South Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations Beat · Financials1 hit
22
Includes a non-GAAP disclosure note for tangible book value.South Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations Beat · Financials1 hit
23
The slide displays four bar charts representing different financial capital ratios.South Plains Financial | Investor Presentation Deck | 27 slides · South Plains Financial
Pitch deck Investor relations Beat · Financials1 hit
02
Includes company logo and page number 2.Zegna | Results Presentation Deck | 55 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Setup1 hit
07
The slide uses a status-based reporting format (ACHIEVED vs ON TRACK) to communicate progress.Zegna | Results Presentation Deck | 55 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
30
The chart illustrates the movement of cash and debt over the fiscal year.Zegna | Results Presentation Deck | 55 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit